CHAPEL HILL, N.C., Apr 30, 2003 (BUSINESS WIRE) -- POZEN Inc.
(NASDAQ: POZN), a pharmaceutical development company with a portfolio
of product candidates for the treatment of migraine, today announced
it will host a conference call following the release of financial
results for the first quarter ended March 31, 2003. The company will
release results before the market opens on Thursday, May 8, 2003. John
R. Plachetka, Pharm.D., POZEN's chairman, president and chief
executive officer, and Matthew E. Czajkowski, chief financial officer,
will host the conference call the same day at 11:00 a.m. Eastern time.
The conference call will be simulcast live on the Internet and can
be accessed by logging on to www.pozen.com. A replay will be available
for seven days in the Investor Relations section of the company's
website. POZEN's 1st quarter results release can be accessed in the
News section of www.pozen.com and clicking on the release dated May 8,
POZEN is a pharmaceutical development company committed to
building a portfolio of products with significant commercial potential
in select therapeutic areas. POZEN's initial focus is on developing
products for migraine therapy, a global market expected to exceed $3
billion this year. The company's common stock is traded on The Nasdaq
Stock Market under the symbol "POZN."
Chief Financial Officer
Director, Investor Relations